RhumbLine Advisers’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $322K | Buy |
|
|||||
|
2021
Q2 | $419K | Sell |
|
|||||
|
2021
Q1 | $482K | Sell |
|
|||||
|
2020
Q4 | $693K | Buy |
|
|||||
|
2020
Q3 | $553K | Sell |
|
|||||
|
2020
Q2 | $779K | Buy |
|
|||||
|
2020
Q1 | $388K | Sell |
|
|||||
|
2019
Q4 | $1.02M | Buy |
|
|||||
|
2019
Q3 | $653K | Buy |
|
|||||
|
2019
Q2 | $571K | Buy |
|
|||||
|
2019
Q1 | $553K | Sell |
|
|||||
|
2018
Q4 | $516K | Buy |
|
|||||
|
2018
Q3 | $577K | Sell |
|
|||||
|
2018
Q2 | $859K | Sell |
|
|||||
|
2018
Q1 | $749K | Sell |
|
|||||
|
2017
Q4 | $843K | Sell |
|
|||||
|
2017
Q3 | $823K | Sell |
|
|||||
|
2017
Q2 | $693K | Buy |
|
|||||
|
2017
Q1 | $920K | Buy |
|
|||||
|
2016
Q4 | $521K | Buy |
|
|||||
|
2016
Q3 | $395K | Buy |
|
|||||
|
2016
Q2 | $255K | Buy |
|
|||||
|
2016
Q1 | $124K | Buy |
|
|||||
|
2015
Q4 | $258K | Buy |
|
|||||
|
2015
Q3 | $172K | Buy |
|
|||||
|
2015
Q2 | $239K | Buy |
|